An actively managed exchange-traded fund focused on companies developing genomic technologies, including gene editing, molecular diagnostics, agricultural biology, and bioinformatics. The portfolio primarily holds biotechnology and life sciences firms that ARK Invest believes could benefit from adva...
1 member of Congress has disclosed 4 trades in ARK Genomic Revolution ETF (ARKG), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |
| 2022-03-25 | Dwight Evans | sell | $1K – $15K |
| 2021-11-02 | Dwight Evans | sell | $1K – $15K |
| 2020-10-29 | Dwight Evans | buy | $1K – $15K |